Molecular Dx
Significance 7/10
CRISPR-based lipid lowering redefines laboratory medicine's role in gene editing era
This Clinical Chemistry piece examines how CRISPR-based interventions for permanent lipid lowering are reshaping the landscape of laboratory medicine. As gene editing therapies targeting lipid pathways move toward clinical reality, clinical laboratories will need to adapt monitoring strategies and develop new assays to support this therapeutic paradigm shift.
The original study
Permanent Lipid Lowering with CRISPR-Based Interventions: Redefining Laboratory Medicine in the Era of Gene Editing.
- Authors
- Zubiran R, Remaley AT
- Journal
- Clinical chemistry
- PMID
- 41854605